Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 3
Submit an article Journal homepage
46
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure

Franciosa JA: Fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure. Expert Opin.Pharmacother. (2006) 7(18):2521-2531.

John M Flack Professor of Medicine and Physiology and Interim Chairman and Chief, Wayne State University, Division of Translational Research and Clinical Epidemiology, Department of Internal Medicine, USA. Email: [email protected]
Pages 275-277 | Published online: 01 Feb 2007

Bibliography

  • TAYLOR AL, ZIESCHE S, YANCY C, CARSON P et al. For the African American Heart Failure Trial Investigators: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N. Engl. J. Med. (2004) 351:2049-2057.
  • FRANCIOSA JA: Fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure. Expert Opin. Pharmacother. (2006) 7(18):2521-2531.
  • COHN JN, ARCHIBALD DG, ZIESCHE S, FRANCIOSA JA et al.: Effect of vasodilator therapy on mortality in chronic congestive heart failure. N. Engl. J. Med. (1986) 314:1547-1542.
  • COHN JN, JOHNSON G, ZIESCHE S, COBB F et al.: A comparison of enalapril with isosorbide dinitrate/hydralazine in the treatment of chronic congestive heart failure. N. Engl. J. Med. (1991) 325:303-310.
  • CARSON P, ZIESCHE S, JOHNSON G, COHN JN FOR THE VASODILATOR-HEART TRIAL STUDY GROUP: Racial differences in response to therapy for heart failure: analysis of vasodilator-heart failure trials. J. Card. Fail. (1999) 5(3):178-187.
  • PACKER M, O’CONNOR CM, GHALI JE, PRESSLER ML et al.: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective randomized amlodipine survival evaluation study group. N. Engl. J. Med. (1996) 355(15):1107-1114.
  • EXNER DV, DRIES DL, DOMANSKI MJ, COHN JN: Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N. Engl. J. Med. (2001) 344(18):1351-1357.
  • DRIES DL, STRONG MH, COOPER RS, DRAZNER MH: Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. J. Am. Coll. Cardiol. (2002) 40:311-317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.